JP7096956B2 - 精製方法 - Google Patents
精製方法 Download PDFInfo
- Publication number
- JP7096956B2 JP7096956B2 JP2022517272A JP2022517272A JP7096956B2 JP 7096956 B2 JP7096956 B2 JP 7096956B2 JP 2022517272 A JP2022517272 A JP 2022517272A JP 2022517272 A JP2022517272 A JP 2022517272A JP 7096956 B2 JP7096956 B2 JP 7096956B2
- Authority
- JP
- Japan
- Prior art keywords
- wavelength
- infrared
- infrared rays
- solution
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000746 purification Methods 0.000 title claims description 20
- 238000000034 method Methods 0.000 title claims description 19
- 239000013078 crystal Substances 0.000 claims description 76
- 239000002904 solvent Substances 0.000 claims description 59
- 229910052751 metal Inorganic materials 0.000 claims description 37
- 239000002184 metal Substances 0.000 claims description 37
- 150000001875 compounds Chemical class 0.000 claims description 24
- 239000000758 substrate Substances 0.000 claims description 9
- BQSJTQLCZDPROO-UHFFFAOYSA-N febuxostat Chemical compound C1=C(C#N)C(OCC(C)C)=CC=C1C1=NC(C)=C(C(O)=O)S1 BQSJTQLCZDPROO-UHFFFAOYSA-N 0.000 claims description 8
- YMBXTVYHTMGZDW-UHFFFAOYSA-N loxoprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1CC1C(=O)CCC1 YMBXTVYHTMGZDW-UHFFFAOYSA-N 0.000 claims description 8
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 claims description 7
- 229960000623 carbamazepine Drugs 0.000 claims description 7
- 229960005101 febuxostat Drugs 0.000 claims description 7
- 229960002373 loxoprofen Drugs 0.000 claims description 7
- 239000010410 layer Substances 0.000 description 43
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 31
- 239000004020 conductor Substances 0.000 description 26
- 238000010438 heat treatment Methods 0.000 description 18
- 238000000862 absorption spectrum Methods 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 150000002894 organic compounds Chemical class 0.000 description 12
- 230000005855 radiation Effects 0.000 description 11
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 238000002441 X-ray diffraction Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 238000004090 dissolution Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000001678 irradiating effect Effects 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000012790 adhesive layer Substances 0.000 description 4
- 239000011651 chromium Substances 0.000 description 4
- 230000000737 periodic effect Effects 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000001376 precipitating effect Effects 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 239000012212 insulator Substances 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 229910052707 ruthenium Inorganic materials 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- 229910002060 Fe-Cr-Al alloy Inorganic materials 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 229910018487 Ni—Cr Inorganic materials 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 239000003759 ester based solvent Substances 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000005453 ketone based solvent Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- -1 terfenazine Chemical compound 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/0063—Control or regulation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
- C07C227/42—Crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
- C07D223/26—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a double bond between positions 10 and 11
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/54—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
- C30B7/02—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions by evaporation of the solvent
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
- C30B7/02—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions by evaporation of the solvent
- C30B7/06—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions by evaporation of the solvent using non-aqueous solvents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/0018—Evaporation of components of the mixture to be separated
- B01D9/0031—Evaporation of components of the mixture to be separated by heating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/0077—Screening for crystallisation conditions or for crystal forms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
少なくとも1つの結晶形を持つ化合物を結晶化させる精製方法であって、
前記化合物を溶媒に溶解させた溶液から特定の結晶形が析出する特定の赤外線波長及び特定の温度をそれぞれ目標波長及び目的温度に設定し、前記目標波長を含む赤外線を放出可能な赤外線放出装置を用いて、前記溶液に前記目標波長を含む赤外線を照射させると共に前記溶液の温度が前記目的温度になるように調節しながら、前記溶媒を蒸発させて前記特定の結晶形を析出させる、
ものである。
フェブキソスタットは、複数の結晶形F1,F2,Q,H1を有することが知られている。各結晶形の赤外線吸収スペクトルのグラフを図3に示す。各結晶形の赤外線吸収スペクトルの波長3.7μm,6.7μmにおける吸収率を表1に示す。
結晶を析出させるときの溶液の温度を40℃から55℃に変更した以外は、実施例1と同様にして結晶を析出させた。析出した結晶について、XRD分析によって結晶形を同定したところ、結晶形はH1であった。
ロキソプロフェンは、複数の結晶形F1,F2を有することが知られている。各結晶形の赤外線吸収スペクトルのグラフを図4に示す。各結晶形の赤外線吸収スペクトルの波長3.7μm,6.7μmにおける吸収率を表1に示す。
結晶を析出させるときの溶液の温度を80℃から55℃に変更した以外は、実施例3と同様にして結晶を析出させた。ここでは、加熱プレートを使用しなかった。析出した結晶について、XRD分析によって結晶形を同定したところ、結晶形はF2であった。
カルバマゼピンは、複数の結晶形F1,F2,F3,F4を有することが知られている。各結晶形の赤外線吸収スペクトルのグラフを図5に示す。各結晶形の赤外線吸収スペクトルの波長3.0μm,6.7μmにおける吸収率を表1に示す。
結晶を析出させるときの溶液の温度を55℃から80℃に変更した以外は、実施例5と同様にして結晶を析出させた。ここでは、ペルチェ素子を利用した加熱プレートを使用して溶液の温度を80℃に調節した。析出した結晶について、XRD分析によって結晶形を同定したところ、結晶形はF3であった。
Claims (5)
- 複数の結晶形を持つ化合物を結晶化させる精製方法であって、
前記化合物を溶媒に溶解させた溶液から特定の結晶形が析出する特定の赤外線波長及び特定の温度をそれぞれ目標波長及び目的温度に設定し、前記目標波長を含む赤外線を放出可能な赤外線放出装置を用いて、前記溶液に前記目標波長を含む赤外線を照射させると共に前記溶液の温度が前記目的温度になるように調節しながら前記溶媒を蒸発させて前記特定の結晶形を析出させる、
精製方法。 - 前記赤外線放出装置は、板状の放射体と、熱源としての面状ヒーターとを有する、
請求項1に記載の精製方法。 - 前記赤外線放出装置は、前記目標波長にピークを有する赤外線を放出可能である、
請求項1又は2に記載の精製方法。 - 前記赤外線放出装置は、外から内に向かって金属パターンと誘電体層と金属基板とがこの順に積層された構造体から前記目標波長にピークを有する赤外線を放出するものであり、前記金属パターンは、前記誘電体層状に同じ形状で同じサイズの金属電極が互いに等間隔に配列されたものであり、前記金属電極の幅に応じて放射する赤外線のピーク波長が変化する、
請求項3に記載の精製方法。 - 前記化合物は、フェブキソスタット、ロキソプロフェン又はカルバマゼピンである、
請求項1~4のいずれか1項に記載の精製方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020027266 | 2020-07-13 | ||
JPPCT/JP2020/027266 | 2020-07-13 | ||
PCT/JP2021/025389 WO2022014396A1 (ja) | 2020-07-13 | 2021-07-06 | 精製方法 |
Publications (3)
Publication Number | Publication Date |
---|---|
JPWO2022014396A1 JPWO2022014396A1 (ja) | 2022-01-20 |
JPWO2022014396A5 JPWO2022014396A5 (ja) | 2022-06-27 |
JP7096956B2 true JP7096956B2 (ja) | 2022-07-06 |
Family
ID=79555315
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022517274A Active JP7096958B2 (ja) | 2020-07-13 | 2021-07-06 | 精製方法 |
JP2022517272A Active JP7096956B2 (ja) | 2020-07-13 | 2021-07-06 | 精製方法 |
JP2022517273A Active JP7096957B2 (ja) | 2020-07-13 | 2021-07-06 | 精製方法 |
JP2022098548A Pending JP2022125073A (ja) | 2020-07-13 | 2022-06-20 | 精製方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022517274A Active JP7096958B2 (ja) | 2020-07-13 | 2021-07-06 | 精製方法 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022517273A Active JP7096957B2 (ja) | 2020-07-13 | 2021-07-06 | 精製方法 |
JP2022098548A Pending JP2022125073A (ja) | 2020-07-13 | 2022-06-20 | 精製方法 |
Country Status (5)
Country | Link |
---|---|
US (3) | US20230150957A1 (ja) |
EP (3) | EP4180104A4 (ja) |
JP (4) | JP7096958B2 (ja) |
CN (3) | CN115315299B (ja) |
WO (3) | WO2022014397A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102485717B1 (ko) * | 2017-09-01 | 2023-01-09 | 삼성전자주식회사 | 공기조화기 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003319800A (ja) | 2002-05-07 | 2003-11-11 | Itochu Seito Kk | 砂糖の製造方法 |
JP2005524595A (ja) | 2002-03-21 | 2005-08-18 | バークシャー ラボラトリーズ,インコーポレイティド | 物質及びシステムにおける結晶成長、結晶化、構造及び相をコントロールする方法 |
JP2009510163A (ja) | 2005-10-03 | 2009-03-12 | マリンクロッド・インコーポレイテッド | ヘミ酒石酸および酒石酸ゾルピデム多形の製造方法 |
JP2012529537A (ja) | 2009-06-10 | 2012-11-22 | テバ ファーマシューティカル インダストリーズ リミティド | フェブキソスタットの結晶形 |
WO2015053297A1 (ja) | 2013-10-08 | 2015-04-16 | Meiji Seikaファルマ株式会社 | ジアザビシクロオクタン誘導体の結晶とその製造法 |
JP2017512781A (ja) | 2014-03-19 | 2017-05-25 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | 溶液から物質を分離するための方法及びデバイス |
WO2018034305A1 (ja) | 2016-08-19 | 2018-02-22 | 日本碍子株式会社 | 有機化合物の精製方法 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58181858A (ja) | 1982-04-19 | 1983-10-24 | Taiyo Sanso Kk | ステンレス鋼の鍍金前処理法 |
GB2122602B (en) * | 1982-06-07 | 1985-06-05 | Hisamitsu Pharmaceutical Co | Novel 2 3-dihydro-indene derivatives |
JPH0744154B2 (ja) * | 1987-12-16 | 1995-05-15 | 株式会社豊田中央研究所 | 光照射型低温mocvd方法および装置 |
JP3805533B2 (ja) * | 1998-07-21 | 2006-08-02 | 東京瓦斯株式会社 | 同位体分離方法 |
DE60042551D1 (de) * | 1999-07-06 | 2009-08-27 | Ventures Holding Intellectual | Verfahren zur kontrolle von kristallformen mit hilfe von laserlicht |
RU2160795C1 (ru) * | 1999-07-07 | 2000-12-20 | Уральский государственный технический университет | Способ получения высокочистых веществ |
JP2001247526A (ja) * | 2000-03-06 | 2001-09-11 | Toyobo Co Ltd | 近赤外線吸収化合組成物および近赤外線吸収フィルター |
EP1172646A1 (en) * | 2000-07-13 | 2002-01-16 | Universiteit Leiden | Screening crystallisation conditions of organic compounds |
JP2004226277A (ja) * | 2003-01-23 | 2004-08-12 | Bios Ikagaku Kenkyusho:Kk | 生体物質および化学物質の光学的測定方法および光学的測定装置 |
JP4099762B2 (ja) * | 2003-03-10 | 2008-06-11 | 株式会社石井鐵工所 | 酒石酸塩の析出分離方法及びその方法を用いて得られた赤外線照射飲料 |
CN100417750C (zh) * | 2006-05-23 | 2008-09-10 | 青岛大学 | 溶液法晶体快速生长装置 |
EP1887004A1 (en) * | 2006-08-07 | 2008-02-13 | Palau Pharma, S.A. | Crystalline forms of (1R,2R)-7-Chloro-3-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]quinazolin-4(3H)-one |
AU2007341356B2 (en) * | 2006-12-28 | 2013-08-29 | F. Hoffmann-La Roche Ag | Crystalline forms Glyt1 |
SG185642A1 (en) * | 2010-07-12 | 2012-12-28 | Yung Shin Pharm Ind Co Ltd | Diclofenac salt of tramadol |
CN102267957B (zh) * | 2011-08-24 | 2013-04-24 | 山东齐都药业有限公司 | 非布司他a晶型的制备方法 |
JP5848621B2 (ja) * | 2012-01-25 | 2016-01-27 | 浜松ホトニクス株式会社 | 薬物評価方法及び薬物評価装置 |
JP2014189462A (ja) | 2013-03-27 | 2014-10-06 | Osaka Univ | 結晶製造方法、準安定形結晶、医薬の製造方法および医薬 |
JP2014214299A (ja) * | 2013-04-30 | 2014-11-17 | 旭硝子株式会社 | 近赤外線吸収粒子、その製造方法、分散液およびその物品 |
CN103333064B (zh) * | 2013-07-17 | 2014-04-23 | 珠海金鸿药业股份有限公司 | 洛索洛芬钠化合物及其药物组合物 |
JP2017061582A (ja) * | 2014-02-07 | 2017-03-30 | 国立研究開発法人産業技術総合研究所 | 蛍光体微粒子の製造方法、蛍光体薄膜、波長変換膜、波長変換デバイス及び太陽電池 |
JPWO2016133170A1 (ja) * | 2015-02-20 | 2017-12-07 | 株式会社クラレ | イオン交換膜 |
US20160289173A1 (en) * | 2015-04-02 | 2016-10-06 | Massachusetts Institute Of Technology | Devices and methods for crystallizing a compound |
GB2548342B (en) * | 2016-03-10 | 2021-04-07 | Rotam Agrochem Int Co Ltd | A novel form of amicarbazone, a process for its preparation and use of the same |
CN107216339B (zh) * | 2016-03-22 | 2021-05-04 | 中国科学院上海药物研究所 | 一种dppiv抑制剂马来酸盐的多晶型及其制备方法 |
CN105753733B (zh) * | 2016-04-15 | 2019-06-18 | 苏州晶云药物科技股份有限公司 | Ahu377的晶型及其制备方法与用途 |
KR20200026871A (ko) * | 2017-07-05 | 2020-03-11 | 엔지케이 인슐레이터 엘티디 | 적외선 처리 장치 |
CN108530382A (zh) * | 2018-03-20 | 2018-09-14 | 华南理工大学 | 一种非布索坦川芎嗪共晶体及其制备方法和用途 |
-
2021
- 2021-07-06 WO PCT/JP2021/025390 patent/WO2022014397A1/ja unknown
- 2021-07-06 WO PCT/JP2021/025388 patent/WO2022014395A1/ja unknown
- 2021-07-06 CN CN202180023519.XA patent/CN115315299B/zh active Active
- 2021-07-06 JP JP2022517274A patent/JP7096958B2/ja active Active
- 2021-07-06 EP EP21841440.7A patent/EP4180104A4/en active Pending
- 2021-07-06 CN CN202180023513.2A patent/CN115315298B/zh active Active
- 2021-07-06 WO PCT/JP2021/025389 patent/WO2022014396A1/ja unknown
- 2021-07-06 JP JP2022517272A patent/JP7096956B2/ja active Active
- 2021-07-06 EP EP21843513.9A patent/EP4180106A4/en active Pending
- 2021-07-06 EP EP21843135.1A patent/EP4180105A4/en active Pending
- 2021-07-06 CN CN202180023504.3A patent/CN115315297B/zh active Active
- 2021-07-06 JP JP2022517273A patent/JP7096957B2/ja active Active
-
2022
- 2022-06-20 JP JP2022098548A patent/JP2022125073A/ja active Pending
- 2022-12-28 US US18/147,229 patent/US20230150957A1/en active Pending
- 2022-12-28 US US18/147,198 patent/US20230167577A1/en active Pending
- 2022-12-28 US US18/147,251 patent/US20230150958A1/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005524595A (ja) | 2002-03-21 | 2005-08-18 | バークシャー ラボラトリーズ,インコーポレイティド | 物質及びシステムにおける結晶成長、結晶化、構造及び相をコントロールする方法 |
JP2003319800A (ja) | 2002-05-07 | 2003-11-11 | Itochu Seito Kk | 砂糖の製造方法 |
JP2009510163A (ja) | 2005-10-03 | 2009-03-12 | マリンクロッド・インコーポレイテッド | ヘミ酒石酸および酒石酸ゾルピデム多形の製造方法 |
JP2012529537A (ja) | 2009-06-10 | 2012-11-22 | テバ ファーマシューティカル インダストリーズ リミティド | フェブキソスタットの結晶形 |
WO2015053297A1 (ja) | 2013-10-08 | 2015-04-16 | Meiji Seikaファルマ株式会社 | ジアザビシクロオクタン誘導体の結晶とその製造法 |
JP2017512781A (ja) | 2014-03-19 | 2017-05-25 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | 溶液から物質を分離するための方法及びデバイス |
WO2018034305A1 (ja) | 2016-08-19 | 2018-02-22 | 日本碍子株式会社 | 有機化合物の精製方法 |
Also Published As
Publication number | Publication date |
---|---|
US20230150957A1 (en) | 2023-05-18 |
EP4180105A1 (en) | 2023-05-17 |
US20230167577A1 (en) | 2023-06-01 |
EP4180106A1 (en) | 2023-05-17 |
US20230150958A1 (en) | 2023-05-18 |
CN115315299A (zh) | 2022-11-08 |
JPWO2022014397A1 (ja) | 2022-01-20 |
EP4180104A4 (en) | 2024-08-28 |
CN115315298A (zh) | 2022-11-08 |
EP4180106A4 (en) | 2024-08-28 |
EP4180104A1 (en) | 2023-05-17 |
JP2022125073A (ja) | 2022-08-26 |
WO2022014397A1 (ja) | 2022-01-20 |
CN115315298B (zh) | 2023-09-15 |
EP4180105A4 (en) | 2024-08-28 |
WO2022014395A1 (ja) | 2022-01-20 |
CN115315297A (zh) | 2022-11-08 |
WO2022014396A1 (ja) | 2022-01-20 |
CN115315297B (zh) | 2024-06-04 |
JP7096957B2 (ja) | 2022-07-06 |
JPWO2022014395A1 (ja) | 2022-01-20 |
JP7096958B2 (ja) | 2022-07-06 |
JPWO2022014396A1 (ja) | 2022-01-20 |
CN115315299B (zh) | 2024-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5380525B2 (ja) | 真空加熱冷却装置 | |
JP7242806B2 (ja) | 有機化合物の精製方法 | |
JP7096956B2 (ja) | 精製方法 | |
US10822292B2 (en) | Method for producing reaction product | |
JPWO2018079386A1 (ja) | 赤外線ヒーター | |
US20200122112A1 (en) | Infrared processing device | |
US20210045195A1 (en) | Infrared radiation device | |
WO2022013919A1 (ja) | 精製方法 | |
WO2023062715A1 (ja) | 低アルコール飲料の製法 | |
US20240351000A1 (en) | Infrared processing device | |
JP2009228120A (ja) | 成膜装置、及び成膜方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220316 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220316 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20220316 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220531 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220624 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7096956 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |